The Leukemia & Lymphoma Society of Canada
Patricia Gilmore is a seasoned professional with extensive experience in marketing and business transformation within the non-profit sector, particularly with The Leukemia & Lymphoma Society of Canada since 2009. Currently serving as Director of Business Transformation, Patricia has held various roles including Business Unit Director for IT and Operations and Director of Marketing Operations. Prior to this, Patricia was Regional Director at Lymphoma Canada, overseeing chapter development and strategic operations in Quebec while managing national marketing initiatives. Patricia's career began with MATT & NAT as Online Marketing and Customer Service Manager, where Patricia significantly enhanced digital presence through strategic website redesigns and marketing efforts. Patricia holds a Bachelor's degree in Commerce with a focus on Marketing from Concordia University and a DEC in Creative Arts and Communications from Dawson College.
This person is not in the org chart
This person is not in any teams
The Leukemia & Lymphoma Society of Canada
The Leukemia & Lymphoma Society of Canada (LLSC) is a voluntary health agency dedicated to blood cancer. LLSC funds lifesaving blood cancer research across Canada and worldwide, and provides free information and support services. We won’t stop until there is a cure for leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative neoplasms and are able to improve the quality of life of people affected by blood cancers and their families by funding life-enhancing research and providing educational resources, services and support. Our strategy to achieve the mission is based on three areas of focus: research, patient support and advocacy. In 2017, we invested almost $7.4 million in the creation of programs and delivery of services to improve the lives of Canadians affected by blood cancers from coast to coast. This investment included a commitment of over $4.1 million in innovative, life-changing research to accelerate new cancer treatments, therapies, and cures; and $3.3 million towards funding patient services, programs and education across Canada. Everything we do is made possible through the generosity of individuals, corporate partners, and foundations. In the last two decades alone, the Leukemia & Lymphoma Society of Canada has raised $207 million for research and services. We receive no government support.